Platform Technology Partners Synaptogenix, Inc. Transaction History

Platform Technology Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	BUY	$1.02 - $181.75 $9,288 - $1.66 Million	9,106 Added 56.8%	25,138 $0
Q1 2022 May 03, 2022	SELL	$6.31 - $10.09 $33,714 - $53,910	-5,343 Reduced 25.0%	16,032 $124,000
Q4 2021 Feb 01, 2022	SELL	$8.38 - $13.72 $93,227 - $152,635	-11,125 Reduced 34.23%	21,375 $182,000
Q2 2021 Aug 05, 2021	BUY	$5.12 - $11.13 $166,400 - $361,725	32,500 New	32,500 $320,000

30K

Ticker SNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,840,630
Market Cap $21M
Description
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

Stay updated on Platform Technology Partners with notifications on news.